Breakthrough Chemistry, Inc. (BKTH)
0.095
-0.01
(-11.22%)
USD |
OTCM |
Oct 08, 16:00
Breakthrough Chemistry EPS Diluted (Quarterly) : -0.1113 for June 30, 2026
EPS Diluted (Quarterly) Chart
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -0.1113 |
| March 31, 2026 | 0.0081 |
| December 31, 2025 | 0.0035 |
| September 30, 2025 | -0.002 |
| June 30, 2025 | -0.0018 |
| March 31, 2024 | -0.0001 |
| December 31, 2023 | -0.0003 |
| September 30, 2023 | 0.00 |
| June 30, 2023 | -0.0001 |
| March 31, 2023 | -0.0108 |
| December 31, 2022 | -0.0033 |
| September 30, 2022 | -0.0003 |
| June 30, 2022 | -0.0051 |
| March 31, 2022 | -0.0045 |
| December 31, 2021 | -0.0001 |
| September 30, 2021 | -0.0003 |
| June 30, 2021 | -0.0001 |
| March 31, 2021 | 0.00 |
| December 31, 2020 | -0.0011 |
| September 30, 2020 | 0.0034 |
| June 30, 2020 | -0.1173 |
| October 31, 2014 | 0.00 |
| July 31, 2014 | 0.00 |
| April 30, 2014 | 0.00 |
| January 31, 2014 | 0.00 |
| Date | Value |
|---|---|
| October 31, 2013 | -0.0003 |
| July 31, 2013 | -0.007 |
| April 30, 2013 | 0.00 |
| January 31, 2013 | 0.00 |
| October 31, 2012 | 0.00 |
| July 31, 2012 | 0.00 |
| April 30, 2012 | 0.00 |
| January 31, 2012 | 0.15 |
| October 31, 2011 | -0.05 |
| July 31, 2011 | -0.95 |
| April 30, 2011 | -3.40 |
| January 31, 2011 | -4.00 |
| October 31, 2010 | -0.15 |
| July 31, 2010 | -15.84 |
| April 30, 2010 | -10.10 |
| January 31, 2010 | -5.40 |
| October 31, 2009 | -10.00 |
| July 31, 2009 | -7.50 |
| April 30, 2009 | -0.025 |
| January 31, 2009 | 7.50 |
| October 31, 2008 | -7.50 |
| July 31, 2008 | -0.025 |
| April 30, 2008 | -4.65 |
| January 31, 2008 | -5.00 |
| October 31, 2007 | -2.50 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Cardiac Biotech Solutions, Inc. | -0.0008 |
| Precision Optics Corp., Inc. | -0.0095 |
| Petros Pharmaceuticals, Inc. | -0.3038 |
| RxSight, Inc. | -0.2916 |
| Vyome Holdings, Inc. | -0.0977 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -1.083M |
| Revenue (Quarterly) | 0.0025M |
| Total Expenses (Quarterly) | 1.085M |
| Enterprise Value | 0.2897M |
| Profit Margin (Quarterly) | -43.31K% |
| Earnings Yield | -107.1% |
| Normalized Earnings Yield | -36.63 |